Sign in

CIK 0001736730 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Camp4 Therapeutics Corp

Sign in to watch
Ticker
CAMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-651-8867
Business address
100 TALCOTT AVENUE, SUITE 201, WATERTOWN, MA, 02472
  1. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  2. S-8 Other Securities Offered to Employees in Benefit Plans
  3. 4 Open-market buy 10% owner bought 909,090 shares at $11.00 ($9,999,990)
  4. 4 Open-market buy 10% owner bought 909,090 shares at $11.00 ($9,999,990)
  5. 4 Open-market buy Director bought 909,090 shares at $11.00 ($9,999,990)
  6. 4 Open-market buy Director bought 909,090 shares at $11.00 ($9,999,990)
  7. 4 Conversion Director acquired 8,917 shares (conversion)
  8. 4 Conversion Director acquired 8,917 shares (conversion)
  9. 4 Conversion Chief Executive Officer acquired 605 shares (conversion)
  10. 3 Insider Initial Statement of Ownership
  11. 8-K Event Bylaws or fiscal year change
  12. 424B4 Offering Prospectus
  13. EFFECT Other Notice of Effectiveness
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 8 of 10 · 193 filings